- Hong Kong Researchers Find Common Ulcer Drug Could Be Effective in Halting Coronavirus Replication in Patients
HONG KONG — A drug commonly used to treat stomach ulcers has shown promise in preventing the Sars-CoV-2 coronavirus from replicating in an animal model, a study by Hong Kong’s top university has found.
The findings of the research, led by University of Hong Kong (HKU) scientists and published in Nature Microbiology on Wednesday (Oct 14), could provide a new and readily available treatment option for Sars-CoV-2, the virus that causes the disease Covid-19.
The researchers said the drug, ranitidine bismuth citrate (RBC), could achieve similar outcomes to the coronavirus drug remdesivir, but at a lower cost. RBC contains a metal called bismuth, which researchers said could reduce viral loads in coronavirus-infected human and animal cells to less than a thousandth of their previous levels.